1. Home
  2. APVO vs JOB Comparison

APVO vs JOB Comparison

Compare APVO & JOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APVO
  • JOB
  • Stock Information
  • Founded
  • APVO 2016
  • JOB 1893
  • Country
  • APVO United States
  • JOB United States
  • Employees
  • APVO N/A
  • JOB N/A
  • Industry
  • APVO Biotechnology: Pharmaceutical Preparations
  • JOB Diversified Commercial Services
  • Sector
  • APVO Health Care
  • JOB Consumer Discretionary
  • Exchange
  • APVO Nasdaq
  • JOB Nasdaq
  • Market Cap
  • APVO 21.7M
  • JOB 22.5M
  • IPO Year
  • APVO N/A
  • JOB N/A
  • Fundamental
  • Price
  • APVO $1.46
  • JOB $0.20
  • Analyst Decision
  • APVO
  • JOB
  • Analyst Count
  • APVO 0
  • JOB 0
  • Target Price
  • APVO N/A
  • JOB N/A
  • AVG Volume (30 Days)
  • APVO 4.5M
  • JOB 223.8K
  • Earning Date
  • APVO 11-10-2025
  • JOB 12-18-2025
  • Dividend Yield
  • APVO N/A
  • JOB N/A
  • EPS Growth
  • APVO N/A
  • JOB N/A
  • EPS
  • APVO N/A
  • JOB N/A
  • Revenue
  • APVO N/A
  • JOB $108,752,000.00
  • Revenue This Year
  • APVO N/A
  • JOB $43.94
  • Revenue Next Year
  • APVO N/A
  • JOB N/A
  • P/E Ratio
  • APVO N/A
  • JOB N/A
  • Revenue Growth
  • APVO N/A
  • JOB N/A
  • 52 Week Low
  • APVO $1.32
  • JOB $0.17
  • 52 Week High
  • APVO $298.00
  • JOB $0.51
  • Technical
  • Relative Strength Index (RSI)
  • APVO 42.13
  • JOB 45.21
  • Support Level
  • APVO $1.48
  • JOB $0.19
  • Resistance Level
  • APVO $1.57
  • JOB $0.21
  • Average True Range (ATR)
  • APVO 0.09
  • JOB 0.01
  • MACD
  • APVO 0.00
  • JOB -0.00
  • Stochastic Oscillator
  • APVO 0.00
  • JOB 48.78

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

About JOB GEE Group Inc.

GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.

Share on Social Networks: